Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: Comparison of zidovudine with tenofovir/abacavir

Johan van Griensven, Rony Zachariah, Freya Rasschaert, Edi F. Atté, Tony Reid
Transactions of the Royal Society of Tropical Medicine and Hygiene 2009;103(6):613-9. (doi: 10.1016/j.trstmh.2008.08.015)

View more related news & stories

Story Jul 26, 2024

When does hunger become famine?

An MSF worker meets with community members to share information about the services that are available to them.

News Jul 26, 2024

ViiV must urgently help get more people on lifesaving HIV prevention m...

Muhammad Ahsan, 47, has completed his hepatitis C treatment at the MSF clinic in Machar Colony, Karachi, Pakistan.

Story Jul 26, 2024

Overcoming hepatitis C in Pakistan: Muhammad Ahsan’s journey

View more related news & stories

Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: Comparison of zidovudine with tenofovir/abacavir

We speak out. Get updates.

How we use funds

Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: Comparison of zidovudine with tenofovir/abacavir

Share

More news and stories